<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Ekologiya cheloveka (Human Ecology)</journal-id><journal-title-group><journal-title xml:lang="en">Ekologiya cheloveka (Human Ecology)</journal-title><trans-title-group xml:lang="ru"><trans-title>Экология человека</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-0869</issn><issn publication-format="electronic">2949-1444</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">643122</article-id><article-id pub-id-type="doi">10.17816/humeco643122</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL STUDY ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Evaluation of cytokines, antibodies to neurotransmitter receptors, and their interrelations in individuals with hand-arm vibration syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка цитокинов, антител к рецепторам нейромедиаторов и их взаимосвязей у лиц с вибрационной болезнью</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>评估振动病患者的细胞因子、神经递质受体抗体及其相互关系</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1400-6345</contrib-id><contrib-id contrib-id-type="spin">3794-7520</contrib-id><name-alternatives><name xml:lang="en"><surname>Masnavieva</surname><given-names>Liudmila B.</given-names></name><name xml:lang="ru"><surname>Маснавиева</surname><given-names>Людмила Борисовна</given-names></name><name xml:lang="zh"><surname>Masnavieva</surname><given-names>Liudmila B.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Biology)</p></bio><bio xml:lang="ru"><p>д-р биол. наук</p></bio><bio xml:lang="zh"><p>Dr. Sci. (Biology)</p></bio><email>Masnavieva_Luda@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0428-3063</contrib-id><contrib-id contrib-id-type="spin">7751-8515</contrib-id><name-alternatives><name xml:lang="en"><surname>Bodienkova</surname><given-names>Galina M.</given-names></name><name xml:lang="ru"><surname>Бодиенкова</surname><given-names>Галина Михайловна</given-names></name><name xml:lang="zh"><surname>Bodienkova</surname><given-names>Galina M.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук., профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><email>immun11@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2025-8303</contrib-id><contrib-id contrib-id-type="spin">9326-7806</contrib-id><name-alternatives><name xml:lang="en"><surname>Boklazhenko</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Боклаженко</surname><given-names>Елена Валерьевна</given-names></name><name xml:lang="zh"><surname>Boklazhenko</surname><given-names>Elena V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>immun11@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">East-Siberian Institute of Medical and Ecological Research</institution></aff><aff><institution xml:lang="ru">Восточно-Сибирский институт медико-экологических исследований</institution></aff><aff><institution xml:lang="zh">East-Siberian Institute of Medical and Ecological Research</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-01-27" publication-format="electronic"><day>27</day><month>01</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-12-26" publication-format="electronic"><day>26</day><month>12</month><year>2024</year></pub-date><volume>31</volume><issue>7</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>512</fpage><lpage>520</lpage><history><date date-type="received" iso-8601-date="2024-12-17"><day>17</day><month>12</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-01-09"><day>09</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2024,</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hum-ecol.ru/1728-0869/article/view/643122">https://hum-ecol.ru/1728-0869/article/view/643122</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND</bold>: One of the primary objectives of the healthcare system in the Russian Federation is to preserve the health of the working population, as economic losses associated with the treatment and social support of individuals with occupational diseases is over 200 billion rubles. Hand-arm vibration syndrome and sensorineural hearing loss continue to prevail among the occupational pathologies. Patients with these conditions have been found to exhibit disturbances in the neuroimmune-endocrine system.</p> <p><bold>AIM</bold>: To compare, identify interrelations, and analyze the levels of cytokines and autoantibodies to neurotransmitter receptors in individuals with hand-arm vibration syndrome, depending on the presence/absence of sensorineural hearing loss and the type of vibration exposure.</p> <p><bold>MATERIALS AND METHODS</bold>:<bold> </bold>Serum levels of interleukins (IL-1β, IL-4, IL-6, IL-8), tumor necrosis factor (TNF-α), and autoantibodies to acetylcholine, glutamate, GABA, dopamine, and serotonin receptors were studied using enzyme-linked immunosorbent assay in patients with hand-arm vibration syndrome of various etiologies, either caused by localized vibration exposure or by combined localized and whole-body vibration exposure, with or without concurrent sensorineural hearing loss.</p> <p><bold>RESULTS</bold>: When accompanied by sensorineural hearing loss, individuals with vibration disease of any etiology exhibited higher IL-1β and IL-6 levels compared with those with hand-arm vibration syndrome due to localized vibration exposure without sensorineural hearing loss. For each subgroup, except for individuals with hand-arm vibration syndrome caused by combined localized and whole-body vibration exposure without sensorineural hearing loss, regression equations demonstrated the contribution of cytokines to the variation in antibody levels against neurotransmitter receptors.</p> <p><bold>CONCLUSION</bold>:<bold> </bold>The findings confirm a higher risk of neuroimmune inflammation in patients with hand-arm vibration syndrome caused by combined whole-body and localized vibration exposure compared to those with vibration disease resulting from localized vibration alone. The presence of concurrent sensorineural hearing loss exacerbates pathological processes due to imbalances in cytokine profiles and neurotransmitter metabolism. Distinctive interrelations between autoantibodies to neurotransmitter receptors and cytokines were identified in individuals with vibration disease of various etiologies and concurrent sensorineural hearing loss.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Одной из основных задач здравоохранения Российской Федерации является сохранение здоровья работающего населения, поскольку экономические потери на лечение и социальные выплаты лицам с профессиональными заболеваниями составляют более 200 млрд рублей. Лидирующие позиции в структуре профессиональной патологии продолжают занимать вибрационная болезнь и нейросенсорная тугоухость. У пациентов с данными заболеваниями установлены нарушения в нейроиммуноэндокринной системе.</p> <p><bold>Цель</bold>.<italic> </italic>Сопоставить и выявить взаимосвязь и проанализировать уровни цитокинов и аутоантител к рецепторам нейромедиаторов у лиц с вибрационной болезнью в зависимости от наличия или отсутствия нейросенсорной тугоухости и вида воздействующей вибрации.</p> <p><bold>Материалы и методы.</bold> У пациентов с вибрационной болезнью различного этиогенеза, обусловленной воздействием локальной вибрации или комбинированным воздействием локальной и общей вибрации, а также отягощённой нейросенсорной тугоухостью и без таковой, с помощью иммуноферментного анализа изучены сывороточные уровни интерлейкинов (IL-1β, IL-4, Il-6, IL-8), фактора некроза опухоли (TNF-α) и аутоантител к рецепторам ацетилхолина, глутамата, ГАМК, дофамина, серотонина.</p> <p><bold>Результаты.</bold> Установлено, что у лиц с вибрационной болезнью любого генеза, сопровождающейся нейросенсорной тугоухостью, уровень IL-1β и IL-6 выше при сопоставлении с вибрационной болезнью, обусловленной воздействием локальной вибрации, без нейросенсорной тугоухости. Для каждой из подгрупп, за исключением лиц с вибрационной болезнью, обусловленной комбинированным воздействием локальной и общей вибрации, не имеющих нейросенсорной тугоухости, показаны регрессионные уравнения, свидетельствующие о вкладе цитокинов в изменение уровней антител к рецепторам нейромедиаторов.</p> <p><bold>Заключение. </bold>Полученные данные подтверждают более высокие риски развития нейроиммунного воспаления у пациентов с вибрационной болезнью при комбинированном воздействии общей и локальной вибрации относительно пациентов с вибрационной болезнью, обусловленной воздействием локальной вибрации. Наличие сопутствующей нейросенсорной тугоухости усугубляет течение патологических процессов за счёт дисбаланса в цитокиновом профиле и нейромедиаторном обмене. Выявлены отличительные особенности взаимосвязей аутоантител к нейромедиаторным рецепторам и цитокинов у лиц с вибрационной болезнью различного этиогенеза и сопутствующей нейросенсорной тугоухостью.</p></trans-abstract><trans-abstract xml:lang="zh"><p>背景。维护劳动人口的健康是俄罗斯联邦医疗卫生体系的优先任务之一，因为职业病患者的治疗和社会补助导致的经济损失超过 2000 亿卢布。在职业病谱系中，振动病及其并发的神经性听力损失仍占据主要地位。研究表明，这些患者的神经-免疫-内分泌系统功能受到显著损害。</p> <p>研究目的。评估振动病患者的细胞因子水平及其针对神经递质受体的自身抗体水平，分析其相互关系，并探讨这些指标在不同振动暴露类型及伴或不伴神经性听力损失情况下的特点。</p> <p>材料与方法。 研究纳入因局部振动或局部与全身振动联合暴露所致的振动病患者，分为伴或不伴神经性听力损失的亚组。采用酶联免疫吸附分析（ELISA）测定血清中细胞因子水平，包括白细胞介素（IL-1β、IL-4、IL-6、IL-8）、肿瘤坏死因子 α（TNF-α），以及针对乙酰胆碱、谷氨酸、γ-氨基丁酸（GABA）、多巴胺和血清素受体的自身抗体水平。</p> <p>结果。研究发现，伴有神经性听力损失的振动病患者 IL-1β 和 IL-6 水平显著高于仅由局部振动引起但未发生听力损害的患者。此外，除局部与全身振动联合暴露但未合并听力损失的亚组外，其余各组均建立了回归方程，表明细胞因子水平与神经递质受体抗体之间的显著相关性。</p> <p>结论。 研究结果证实，与单纯局部振动所致的振动病相比，局部与全身振动联合暴露可显著增加神经免疫炎症的发生风险。此外，伴发神经性听力损失的患者病理进程更为严重，这可能与细胞因子失衡及神经递质系统功能障碍相关。本研究揭示了不同病因所致振动病及其伴发神经性听力损失患者的自身抗体-神经递质受体与细胞因子的相互作用特征。</p></trans-abstract><kwd-group xml:lang="en"><kwd>cytokines</kwd><kwd>antibodies</kwd><kwd>neuronal receptors</kwd><kwd>hand-arm vibration syndrome</kwd><kwd>sensorineural hearing loss</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>цитокины</kwd><kwd>антитела</kwd><kwd>нейрональные рецепторы</kwd><kwd>вибрационная болезнь</kwd><kwd>нейросенсорная тугоухость</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>细胞因子</kwd><kwd>抗体</kwd><kwd>神经递质受体</kwd><kwd>振动病</kwd><kwd>神经性听力损失</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Правительство РФ</institution></institution-wrap><institution-wrap><institution xml:lang="en">Government of RF</institution></institution-wrap><institution-wrap><institution xml:lang="zh">俄羅斯聯邦政府</institution></institution-wrap></funding-source></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Khrupachev AG, Khadartsev AA, Sedova OA, et al. Quantitative assessment of the harmful effects of industrial noise and vibration on human health. National Interests: Priorities and Security. 2013;9(28):44–52. (In Russ.) EDN: QIYXLR</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Babanov SA, Vorobyova EV. Features of diagnosis and course of vibration disease in the conditions of modern production. Trudnyj Pacient (Difficult Patient). 2010;8(5):28–30. (In Russ.) EDN: OGBNTL</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Bodienkova GM, Boklazhenko EV. Immunochemical markers of effect under exposure to risk factors causing vibration disease of different etiogenesis: comparative assessment. Health Risk Analysis. 2023;(2):149–154. doi: 10.21668/health.risk/2023.2.14 EDN: IMBTYX</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Lapko IV, Kir'yakov VA, Pavlovskaya NA, Zheglova AV. Changes in hormones of pituitary-thyroid and pituitary-genital systems in workers with vibration disease and neurosensory deafness. Russian Journal of Occupational Health and Industrial Ecology. 2015;(10):26–30. EDN: UMUIQD</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Miteva D, Vasilev GV, Velikova T. Role of specific autoantibodies in neurodegenerative diseases: pathogenic antibodies or promising biomarkers for diagnosis. Antibodies (Basel). 2023;12(4):81. doi: 10.3390/antib12040081</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kirschstein T, Köhling R. Functional changes in neuronal circuits due to antibody-driven autoimmune response. Neurobiol Dis. 2023;184:106221. doi: 10.1016/j.nbd.2023.106221</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bodienkova GM, Boklazhenko EV. Comparative assessment of neurochemical indicators in patients with occupational pathology due to physical and chemical factors. Neirokhimiya. 2021;38(4):385–390. doi: 10.31857/S1027813321040026 EDN: KDXRLT</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Poletaev AB Molecular medical examination (new approaches to the early manifestation of pathological changes in the human body: guidelines for doctors. Moscow: Immunculus; 2014. (In Russ.)</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Kashtalyan OA, Ushakova LYu. Cytokines as universal regulation system. Meditsinskie Novosti. 2017;(9):3–7. EDN: ZHRKTB</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Berezhnaya NM, Sepiashvili RI. Interleukins in the pathogenesis of atopic allergic diseases. Allergology and Immunology. 2014;15(3):169–176. (In Russ.) EDN: UCKODP</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ketlinskiy SA, Simbirtsev AS. Cytokines. St. Petersburg: Foliant; 2008. (In Russ.)</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Rukavishnikov VS, Bodienkova GM, Kurchevenko SI, et al. Role of neuroautoimmune integration in pathogenesis of vibration disease. Russian Journal of Occupational Health and Industrial Ecology. 2017;(1):17–20. EDN: XYEXFZ</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Bodienkova GM, Kurchevenko SI. Influence of industrial vibration on the level of antibodies against regulatory proteins of the nervous tissue. Fiziologiya Cheloveka. 2016;42(5):550–553. doi: 10.7868/S0131164616050039 EDN: WLNKEJ</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol. 2001;58(3):365–370 doi: 10.1001/archneur.58.3.365</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Mironova YuS, Zhukova NG, Zhukova IA, et al. Parkinson's disease and glutamatergic system. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(5):138–142. doi: 10.17116/jnevro201811851138 EDN: XROHLV</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kuzmina USh, Zainullina LF, Vakhitov VA, et al. The role of glutamate in the pathogenesis of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8):160–167. doi: 10.17116/jnevro2019119081160 EDN: LMTRSO</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kolobov VV, Zakharova IA, Fomina VG, et al. Effect of antibodies to glutamate on caspase-3 activity in brain structures of rats with experimental Alzheimer’s disease. Bulletin of Experimental Biology and Medicine. 2013;154(4):425–427 doi: 10.1007/s10517-013-1967-x EDN: RFJFTJ</mixed-citation></ref></ref-list></back></article>
